Still Seeking Pharma Partner, Phoenix Bio Adds $1M in Angel Funding

Phoenix Biotechnology, which has been developing an experimental plant-based drug for cancer for more than a decade, has added about $1 million in new funding, according to a securities filing and the company’s top scientist.